Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Clinicopathological data of PDAC patients and cancer-free controls in proteomic analysis

From: Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients

No. of samples Sex Age Histology* Tumor location Metastases
PDAC      
1 female 55 Moderately differentiated ductal adenocarcinoma Tail of pancreas Yes
2 male 65 Well differentiated ductal adenocarcinoma Head of pancreas No
3 male 38 Well differentiated ductal adenocarcinoma Head of pancreas Yes
4 male 57 Moderately differentiated ductal adenocarcinoma Body of pancreas Yes
5 female 53 Poorly differentiated ductal adenocarcinoma Head of pancreas No
6 male 59 Moderately differentiated ductal adenocarcinoma Head of pancreas Yes
7 female 44 Moderately differentiated ductal adenocarcinoma Tail of pancreas Yes
8 female 51 Well differentiated ductal adenocarcinoma Head of pancreas No
9 male 48 Moderately differentiated ductal adenocarcinoma Tail of pancreas No
Cancer-free   Clinical diagnosis   
1 male 53 Chronic pancreatitis   
2 female 66 benign cystic neoplasm of pancreas   
3 male 49 Gallstone pancreatitis   
4 male 50 Chronic pancreatitis   
5 female 52 benign cystic neoplasm of pancreas   
6 female 57 benign cystic neoplasm of pancreas   
7 male 46 Chronic pancreatitis   
8 female 47 cystic fibrosis of pancreas   
9 male 60 Chronic pancreatitis   
  1. * PDAC differentiation was classified according to the WHO standard (2nd edition, 1996).